Screening for Hemoglobinopathies in Pregnant Women

This prospective monocentric study project is to identify hemoglobinopathies in pregnant women in order to optimize antenatal care and to investigate the prevalence of hemoglobinopathies in pregnant women in Switzerland.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Hemoglobinopathies Anemia Anemia, Hemolytic Anemia, Hemolytic, Congenital Anemia, Sickle Cell Congenital, Hereditary, and Neonatal Diseases and Abnormalities Genetic Diseases, Inborn Hematologic Diseases Hemic and Lymphatic Diseases Thalassemia

Sex eligibility

Female

Study type

Observational

Primary location

Frauenklinik University Hospital Basel

Basel, 4031, Switzerland

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

pregnant women seen at the Frauenklinik at University Hospital Basel

Exclusion criteria

pregnant women with already known hemoglobinopathy
refusal of participation

Treatment and study plan

Review of routine lab data

Diagnostic Test

Review of routine lab data from pregnant women (first trimester)

Primary outcomes

identification of hemoglobinopathies

Time frame: single time point assessment at baseline

identification of hemoglobinopathies by investigating routine lab samples

Sponsors and collaborators

Lead sponsor

University Hospital, Basel, Switzerland

Other

Registry information

Important dates

Study start: 2019
Primary completion: 2019
Study completion: 2019
First posted: Jul 23, 2019
Registry last updated: Mar 4, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed